Privia Health Group, Inc. ( PRVA ) NASDAQ Global Select

Cena: 22.11 ( 0.87% )

Aktualizacja 07-03 22:00
NASDAQ Global Select
Branża: Medical - Healthcare Information Services
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 1 102
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 86%
Ilość akcji: 118 064 000
Debiut giełdowy: 2021-04-28
WWW: https://www.priviahealth.com
CEO: Mr. Parth Mehrotra
Adres: 950 North Glebe Road
Siedziba: 22203 Arlington
ISIN: US74276R1023
Opis firmy:

Privia Health Group, Inc. działa jako krajowa firma lekarska w Stanach Zjednoczonych. Firma współpracuje z grupami medycznymi, planami zdrowotnymi i systemami opieki zdrowotnej w celu optymalizacji praktyk lekarzy, poprawy doświadczeń pacjentów i nagradzania lekarzy za zapewnienie opieki osobiście i wirtualne. Oferuje technologie i narzędzia do zdrowia ludności w celu zwiększenia przepływów pracy niezależnych dostawców; Organizacja usług zarządzania, która umożliwia dostawcom skupienie się na swoich pacjentach poprzez zmniejszenie pracy administracyjnej; jednorazowa grupa medyczna, która ułatwia negocjacje płatników, integrację kliniczną i dostosowanie zachęt finansowych; Odpowiedzialna organizacja opieki, która angażuje pacjentów, ograniczają niewłaściwe wykorzystanie i zwiększają koordynację i wskaźniki jakości pacjentów w celu zwiększenia opieki opartej na wartości; oraz sieć dla nabywców i płatników, którzy umożliwiają dostawcom łączenie się z nowymi populacjami pacjentów i tworzenie niestandardowych umów. Firma została założona w 2007 roku i ma siedzibę w Arlington w stanie Wirginia. Privia Health Group, Inc. była byłą spółką zależną Brighton Health Group Holdings, LLC.

Wskaźniki finansowe
Kapitalizacja (USD) 2 695 651 200
Aktywa: 1 145 565 000
Cena: 22.11
Wskaźnik Altman Z-Score: 4.9
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 184.2
Ilość akcji w obrocie: 86%
Średni wolumen: 871 742
Ilość akcji 121 920 000
Wskaźniki finansowe
Przychody TTM 1 716 318 000
Zobowiązania: 483 383 000
Przedział 52 tyg.: 16.47 - 26.09
Piotroski F-Score: 6
Umiarkowany (średnia jakość finansowa)
EPS: 0.1
P/E branży: 32.4
Beta: 0.761
Raport okresowy: 2025-08-06
WWW: https://www.priviahealth.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David Mountcastle CPA, MBA Executive Vice President, Chief Financial Officer & Principal Accounting Officer 713 720 1970
Mr. Parth Mehrotra Chief Executive Officer & Director 1 186 187 1979
Ms. Dana Fields CPA Chief Audit & Compliance Officer 0 0
Mr. Edward Christopher Fargis Esq. Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary 0 0
Mr. Eric J. Beyer Executive Vice President of Medical Groups 0 0
Mr. Jay Stevens Senior Vice President & Chief Growth Officer 0 0
Mr. Sarath Degala Chief Operating Officer 0 0
Mr. Robert P. Borchert Senior Vice President of Investor Relations & Corporate Communications 0 0
Mr. Chris Voigt Executive Vice President & Chief Technology Officer 0 0
Ms. Jenny Harding Chief People Officer 0 0
Wiadomości dla Privia Health Group, Inc.
Tytuł Treść Źródło Aktualizacja Link
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by. seekingalpha.com 2025-05-11 07:44:02 Czytaj oryginał (ang.)
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-05-08 14:36:47 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-05-08 12:20:40 Czytaj oryginał (ang.)
Privia Health Reports First Quarter 2025 Financial Results Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-08 10:00:00 Czytaj oryginał (ang.)
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-05-07 14:21:36 Czytaj oryginał (ang.)
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential. invezz.com 2025-03-04 09:03:14 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-27 12:36:06 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by. seekingalpha.com 2025-02-27 11:36:51 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q4 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-02-27 10:16:07 Czytaj oryginał (ang.)
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-02-27 08:00:00 Czytaj oryginał (ang.)
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024. zacks.com 2025-02-25 12:20:53 Czytaj oryginał (ang.)
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. globenewswire.com 2025-01-24 11:00:00 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-01-15 14:41:13 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Is the Better Value Option? Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-12-20 14:45:26 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Should Value Investors Buy Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-12-04 14:46:20 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-11-18 14:46:01 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by. seekingalpha.com 2024-11-08 17:50:49 Czytaj oryginał (ang.)
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2024-11-07 12:35:39 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q3 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. zacks.com 2024-11-07 10:15:19 Czytaj oryginał (ang.)
Privia Health Reports Third Quarter 2024 Financial Results ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. globenewswire.com 2024-11-07 08:00:00 Czytaj oryginał (ang.)
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy? Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-10-31 13:05:36 Czytaj oryginał (ang.)
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs globenewswire.com 2024-10-29 19:04:00 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by. seekingalpha.com 2024-08-08 16:45:26 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q2 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-08-08 14:35:42 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q2 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-08-08 12:11:59 Czytaj oryginał (ang.)
Privia Health Reports Second Quarter 2024 Financial Results ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. globenewswire.com 2024-08-08 10:00:00 Czytaj oryginał (ang.)
Earnings Preview: Privia Health (PRVA) Q2 Earnings Expected to Decline Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-08-01 15:05:50 Czytaj oryginał (ang.)
Privia Health to Participate in the William Blair Growth Stock Conference ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT. globenewswire.com 2024-05-30 13:26:00 Czytaj oryginał (ang.)
Insider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout Candidate With the earnings-reporting season winding down, the windows for making insider purchases are opening up. 247wallst.com 2024-05-26 13:15:08 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-05-13 16:46:27 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2024 Earnings Conference Call May 9, 2024 8:00 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Sameer Patel – Evercore ISI Joshua Raskin – Nephron Research David Larsen – BTIG Richard Close – Canaccord Genuity Andrew Mok – Barclays Jeff Garro – Stephens Jack Slevin – Jefferies Jess Tassan – Piper Sandler Ryan Daniels – William Blair Whit Mayo – Leerink Partners Jailendra Singh – Truist Daniel Grosslight – Citi Adam Ron – Bank of America Operator Welcome to the Privia Health First Quarter 2024 Conference Call. seekingalpha.com 2024-05-11 14:35:24 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q1 Earnings The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-05-09 14:36:24 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-05-09 12:10:27 Czytaj oryginał (ang.)